Search by Drug Name or NDC
NDC 65162-0093-06 Milnacipran HCl 50 mg/1 Details
Milnacipran HCl 50 mg/1
Milnacipran HCl is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is MILNACIPRAN HYDROCHLORIDE.
MedlinePlus Drug Summary
Milnacipran is used to treat fibromyalgia (a long-lasting condition that may cause pain, muscle stiffness and tenderness, tiredness, and difficulty falling asleep or staying asleep). Milnacipran is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amount of serotonin and norepinephrine, natural substances that help stop the movement of pain signals in the brain.
Related Packages: 65162-0093-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Milnacipran
Product Information
NDC | 65162-0093 |
---|---|
Product ID | 65162-093_5dd080c7-7abf-479a-9c33-d9bd6a099f04 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Milnacipran HCl |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Milnacipran HCl |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 50 |
Active Ingredient Units | mg/1 |
Substance Name | MILNACIPRAN HYDROCHLORIDE |
Labeler Name | Amneal Pharmaceuticals LLC |
Pharmaceutical Class | Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA205081 |
Listing Certified Through | 2024-12-31 |
Package
NDC 65162-0093-06 (65162009306)
NDC Package Code | 65162-093-06 |
---|---|
Billing NDC | 65162009306 |
Package | 60 TABLET in 1 BOTTLE (65162-093-06) |
Marketing Start Date | 2014-01-31 |
NDC Exclude Flag | N |
Pricing Information | N/A |